An older adult patient reports shortness of breath with minimal exertion. Upon evaluation of their respiratory health, which age-related change in the respiratory system is most likely contributing to this symptom?

A. 30 gtt/min:This rate would deliver approximately 180 mL per hour, meaning the 500 mL would be finished in less than 3 hours. This is much faster than the 8-hour duration prescribed by the physician. Rapid infusion of saline can lead to fluid overload, especially in patients with cardiac or renal issues.

B. 15 gtt/min:At this drip rate, the patient would receive only about 45 mL per hour, totaling 360 mL over 8 hours. This results in an under-infusion that fails to meet the patient's prescribed fluid requirements. It would take over 11 hours to finish the 500 mL bag at this speed.

C. 35 gtt/min:This setting would deliver 105 mL per hour, resulting in the total volume being infused in under 5 hours. This significantly deviates from the 8-hour order and increases the risk of complications associated with rapid fluid administration. It represents a calculation error in the drip rate formula.

D. 21 gtt/min:Using the formula (500 mL multiplied by 20 gtt/mL) divided by 480 minutes, the result is 20.83. Rounding to the nearest whole number gives 21 drops per minute. This precisely ensures that the 500 mL of normal saline is delivered over the intended 8-hour period.

A. They are often addictive: Non-opioid medications do not have the potential for psychological addiction because they do not activate the reward centers of the brain. They lack the mu-receptor agonism responsible for the cravings and compulsive use associated with opioids. This makes them ideal for patients with a history of substance abuse.

B. Primarily used for neuropathic pain: Neuropathic pain usually requires adjuvant medications like gabapentinoids or tricyclic antidepressants to stabilize nerve membranes. Non-opioids are most effective for inflammatory or musculoskeletal pain. While they can be part of a multimodal plan, they are not the primary treatment for nerve damage.

C. Result in respiratory depression: One of the greatest safety advantages of non-opioids is that they do not depress the respiratory center in the medulla. Even at high doses, they do not cause the life-threatening bradypnea associated with opioid toxicity. Their primary risks involve gastrointestinal, renal, or hepatic toxicity instead.

D. Useful for mild to moderate pain: Non-opioid analgesics, such as acetaminophen and NSAIDs, provide effective relief for nociceptive pain without the risk of physical dependence. Unlike opioids, they do not produce euphoria or a "high," making them safer for long-term use in non-malignant pain. They are the first step on the WHO pain ladder.